Cardiac Implantable Electronic Devices in the Fontan Patient

Blandine Mondésert1, Jeremy P Moore2, Paul Khairy1

  • 1Adult Congenital Heart Disease Center, Montreal Heart Institute, Medicine Department, Université de Montréal, Montréal, Québec, Canada.

Insights

Adult Fontan patients require specialized care for arrhythmias, a common complication. Advanced cardiac implantable electronic device (CIED) therapies are crucial for managing these complex cases.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • Fontan patients are aging due to improved pediatric care, necessitating adult multidisciplinary management.
  • These patients face unique challenges including hemodynamic stressors, cardiac/hepatic failure, and prevalent arrhythmias.
  • Arrhythmias in Fontan patients are linked to anatomy, surgical methods, and postoperative outcomes.

Purpose of the Study:

  • To review current knowledge on arrhythmias in adult Fontan patients.
  • To discuss diagnosis, treatment, and prevention strategies, focusing on cardiac implantable electronic devices (CIEDs).
  • To highlight Fontan-specific challenges and emerging technologies for arrhythmia management.

Main Methods:

  • State-of-the-art review of existing literature.
  • Discussion of diagnostic tools and therapeutic options for arrhythmias.
  • Focus on the application and adaptation of CIEDs in Fontan physiology.

Main Results:

  • Arrhythmias are highly prevalent in Fontan survivors and require tailored management strategies.
  • CIED therapies have advanced significantly, offering improved management options.
  • New technologies like subcutaneous ICDs and leadless pacing show promise but need Fontan-specific consideration.

Conclusions:

  • CIEDs are vital for managing arrhythmias in Fontan patients.
  • Managing arrhythmias in this population presents significant electrophysiological challenges.
  • Adapted diagnostic and therapeutic approaches, including novel technologies, are essential for optimal Fontan patient care.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
47
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
202
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
42
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
218